Veículo
Financial News
Em 2025: 0 notícias
Desde 1995: 2 notícias
Latest Tuberculosis Vaccine Results Unveiled at FAPESP Week China
Publicado em 03 de julho de 2024
The Butantan Institute, in collaboration with a number of other researchers, has made significant strides towards creating a more potent version of the BCG vaccine used to combat tuberculosis. While traditional vaccines have been shown to reduce infection by 90% in lab mice, this new recombinant BCG alternative increases that protection rate up to an impressive 99%. Additionally, it also offers longer-lasting protection.
Researchers are particularly interested in strengthening the efficacy [...]
-
New Single-Dose Dengue Vaccine Offers 80% Protection
Publicado em 02 fevereiro 2024A phase 3 trial published in the New England Journal of Medicine (NEJM) has shown promising results for the single-dose tetravalent Butantan-Dengue Vaccine (Butantan D-V). The vaccine demonstrated an impressive 80% protection rate among participants with no prior exposure to dengue and an even higher protection rate of 89% among those previously exposed to the disease. This groundbreaking vaccine is the product of painstaking research undertaken by Brazil's Butantan Institute. The study, [...]ver notícia